http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
BioLife Solutions Launches the IntelliRate™ i67C Liquid Nitrogen (LN2) Controlled-Rate Freezer
-
BioLife Solutions Reports First Quarter 2023 Financial Results
-
BioLife Solutions to Provide First Quarter 2023 Financial Results and Business Update on May 10, 2023
-
BioLife Solutions Reports Preliminary and Unaudited 2022 Fourth Quarter and Full Year Financial Results
-
BioLife Solutions (BLFS) Reports Immaterial Financial Exposure to Silicon Valley Bank
-
BioLife Solutions Reports Immaterial Financial Exposure to Silicon Valley Bank
-
BioLife Solutions to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update on March 16, 2023
-
BioLife Solutions (BLFS) Launches Ultraguard
-
BioLife Solutions Launches Ultraguard™ -70°C Phase Change Material (PCM) Accessory to Provide Backup Cooling in ULT Freezers and Dry Ice Alternative for Benchtop Biologic Material Storage
-
BioLife Solutions Announces 2023 Analyst Day & Participation in Upcoming Investor Conferences
-
BioLife Solutions Named One of Seattle Business Magazine's Washington's Best Companies to Work For
-
BioLife Solutions Announces 2022 Fourth Quarter and Full Year Preliminary Unaudited Revenue and Introduces 2023 Revenue Guidance
-
BioLife Solutions to Announce Preliminary 2022 Revenue and Introduce 2023 Revenue Guidance on January 9, 2023
-
BioLife Solutions (BLFS) Receives 7 Additional Patents
-
BioLife Solutions Expands Intellectual Property Estate
-
BioLife Solutions Named in BioSpace Best Places to Work in Biopharma 2023 Report
-
BioLife Solutions Reports Third Quarter 2022 Financial Results
-
BioLife Solutions to Report Third Quarter 2022 Financial Results and Provide Business Update on November 9, 2022
-
BioLife Solutions (BLFS) and CSafe Partner to Expands Supply Chain Solutions for Cell and Gene Therapies
-
CSafe and BioLife Solutions, Inc. announce partnership to expand supply chain solutions for the cell and gene therapy market
-
BioLife Solutions (BLFS) Announces COO Retirement
-
BioLife Solutions Announces COO to Retire and Join Board of Directors
-
BioLife Solutions (BLFS) Appoints Timothy L. Moore to its Board
-
BioLife Solutions Appoints Cell Therapy Executive Timothy L. Moore to its Board of Directors
-
BioLife Solutions Reports Second Quarter 2022 Financial Results and Updates Full Year 2022 Revenue Guidance
-
BioLife Solutions to Report Second Quarter 2022 Financial Results and Provide Business Update on August 9, 2022
-
BioLife Solutions Deploys SciSafe's Ultra Low Controlled Temperature Trailers to Extend Domestic Cold Chain Services
-
BioLife Solutions Reports First Quarter 2022 Financial Results
-
BioLife Solutions Executes Co-Marketing Agreement with Coriell Institute for Medical Research to Offer Biostorage, Biospecimen Processing and Custom Laboratory Services
-
BioLife Solutions to Report First Quarter 2022 Financial Results and Provide Business Update on May 9, 2022
-
BioLife Solutions (BLFS) Announces Change of Auditor to Grant Thornton LLP
-
BioLife Solutions, Inc. Announces Change of Auditor to Grant Thornton LLP
-
BioLife Solutions Receives Nasdaq Notice of Noncompliance for Delayed 10-K Filing
-
BioLife Solutions (BLFS) Announces Additional Delay in Filing of Annual 10-K Report
-
BioLife Solutions Announces Additional Delay in Filing of Annual Report on Form 10-K
-
BioLife Solutions to Attend and Present at Upcoming Investor Conferences
-
BioLife Solutions Reports Unaudited Fourth Quarter and Full Year 2021 Financial Results
-
BioLife Solutions to Report Fourth Quarter and Full Year 2021 Financial Results and Provide Business Update on February 28, 2022
-
BioLife Solutions (BLFS) Announces Preliminary 2021 Revenue of $119 Million
-
BioLife Solutions Announces Preliminary 2021 Revenue of $119 Million, Up 148% Over 2020
-
BioLife Solutions Collaborates with Seattle Children's to Improve Viral Vector and Cell and Gene Therapy Manufacturing
-
UNICEF Selects Ultra-Low Temperature (ULT) Freezers from BioLife Solutions to Extend Thermal Stability of COVID-19 Vaccines
-
BioLife Solutions Ranks 353 Among Fastest-Growing Companies in North America on the 2021 Deloitte Technology Fast 500™
-
BioLife Solutions Named to Inc. Magazine Inaugural List of Best-Led Companies
-
BioLife Solutions Announces Third Quarter 2021 Financial Results
-
BioLife Solutions Announces Executive Management Changes
-
BioLife Solutions to Report Third Quarter 2021 Financial Results and Provide Business Update on November 11, 2021
-
Biolife Solutions Supports Biostorage Best Practices Through SciSafe's "Centers of Excellence" With New World-Class Facility in Amsterdam
-
BioLife Solutions Leverages Expanded Bioproduction Tools and Services Portfolio in Multipoint Engagement with Leading CAR T-Cell Developer
-
BioLife Solutions (BLFS) Appoints Joydeep Goswami to its Board

